SCHEMBL3357696

SCHEMBL3357696

c1ccc(OCCCCCSCCCCCOc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 2/20 0.70
HDAC1 Q13547 4/20 0.61
HDAC2 Q92769 4/20 0.61
HDAC3 O15379 1/20 0.61
HDAC4 P56524 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
LTA4H P09960 2/20 0.50
TAAR1 Q96RJ0 1/20 0.50
ALDH1A1 P00352 1/20 0.50
RECQL P46063 1/20 0.50
PLA2G4B P0C869 1/20 0.50
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
DRD3 P35462 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535231 0.91 KCNA3 (0.68) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL23014911 0.91 KCNA3 (0.57) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL23014961 0.91 KCNA3 (0.57) KCNA3HDAC1HDAC2HDAC3HDAC4
Ammonia Solution, Strong SCHEMBL23015052 0.89 KCNA3 (0.55) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL10904079 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL9011596 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL31229544 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL497029 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL2512157 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4
SCHEMBL28573982 0.86 KCNA3 (0.94) KCNA3HDAC1HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687482-B2 Bisphosphonate compounds and methods THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2010-03-30 US disclosed
EP-2001486-A2 BISPHOSPHONATE COMPOUNDS AND METHODS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2008-12-17 EP disclosed
US-20070275931-A1 BISPHOSPHONATE COMPOUNDS AND METHODS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2007-11-29 US disclosed
WO-2007109585-A2 BISPHOSPHONATE COMPOUNDS AND METHODS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275931-A1 BISPHOSPHONATE COMPOUNDS AND METHODS FDPS, GGPS1, FNTB KCNA3 3366/4885HDAC1 4221/4885HDAC2 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.